1. Home
  2. NNVC vs MYO Comparison

NNVC vs MYO Comparison

Compare NNVC & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.75

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$0.90

Market Cap

44.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNVC
MYO
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
44.8M
IPO Year
2008
2017

Fundamental Metrics

Financial Performance
Metric
NNVC
MYO
Price
$1.75
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
349.7K
901.7K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
10.00
N/A
EPS
N/A
N/A
Revenue
N/A
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$0.85
$0.61
52 Week High
$2.23
$2.20

Technical Indicators

Market Signals
Indicator
NNVC
MYO
Relative Strength Index (RSI) 61.20 37.44
Support Level $1.18 $0.75
Resistance Level $1.90 $0.99
Average True Range (ATR) 0.15 0.09
MACD 0.03 -0.02
Stochastic Oscillator 78.18 13.23

Price Performance

Historical Comparison
NNVC
MYO

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: